Agile Therapeutics to Report Third Quarter 2023 Financial Results and Provide Business Update on Thursday, November 9, 2023
26 Outubro 2023 - 9:05AM
Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare
company, today announced it will report third quarter 2023
financial results before the market open on Thursday, November 9,
2023. Following the release, the Company will host a live
conference call and webcast at 8:30 a.m. ET to discuss
the Company’s financial results and provide a business update.
Event |
Agile Therapeutics Third Quarter 2023 Financial Results Conference
Call |
Date |
Thursday, November 9,
2023 |
Time |
8:30 a.m. ET / 5:30 a.m.
PT |
A live webcast of the conference call may be
accessed via the Investor Relations portion of the Agile
Therapeutics website
at https://ir.agiletherapeutics.com/events-and-presentations.
To participate in the live conference call via telephone, please
register here. Upon registering, a dial-in number and unique
PIN will be provided to join the conference call.
About Agile
Therapeutics, Inc.
Agile Therapeutics is a women's healthcare
company dedicated to fulfilling the unmet health needs of today’s
women. Our product and product candidates are designed to provide
women with contraceptive options that offer freedom from taking a
daily pill, without committing to a longer-acting method. Our
initial product, Twirla®, (levonorgestrel and ethinyl estradiol)
transdermal system, is a non-daily prescription contraceptive.
Twirla is based on our proprietary transdermal patch technology,
called Skinfusion®, which is designed to allow drug delivery
through the skin. For more information, please visit the company
website at www.agiletherapeutics.com. The Company
may occasionally disseminate material, nonpublic information on the
Company’s website, Twitter account (@agilether), and LinkedIn
account.
Contact:Matt RileyHead of Investor Relations
& Corporate Communicationsmriley@agiletherapeutics.com
Agile Therapeutics (NASDAQ:AGRX)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
Agile Therapeutics (NASDAQ:AGRX)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024